Inventurus Knowledge Solutions IPO Price: ₹1,265 to ₹1,329 per share
IPO Dates: 12 December 2024 – 16 December 2024
Company Overview
Incorporated on September 5, 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a technology-enabled healthcare solutions provider. The company specializes in delivering a care enablement platform that assists physician enterprises primarily in the United States, along with Canada and Australia. IKS focuses on optimizing healthcare delivery by reducing administrative burdens, enabling providers to focus on superior clinical care, population health improvements, and transitioning to value-based care models.
Services and Solutions
IKS Health offers a wide array of services tailored to meet the needs of outpatient and inpatient care organizations. These include:
- Clinical Support: Helping healthcare organizations enhance the quality and efficiency of patient care.
- Medical Documentation Management: Streamlining documentation processes to reduce the administrative workload.
- Virtual Medical Scribing: Providing real-time scribing solutions to aid physicians in maintaining accurate patient records.
- Technology-Enabled Services: Their digital health platform assists clients in building, maintaining, and managing technology systems. The Unifying Data Platform (UDP) aggregates data from multiple systems like billing and electronic health records (EHR), creating a centralized database for effective decision-making.
Key Clientele
As of September 30, 2024, IKS Health serves over 778 healthcare organizations, including:
- Health Systems
- Academic Medical Centers
- Multi-Specialty and Single-Specialty Medical Groups
- Ancillary Healthcare Organizations
Prominent clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.
Workforce and Global Presence
IKS operates with a global workforce of over 13,528 employees, including 2,612 clinically trained professionals. Their consultative sales force has a robust presence across key geographies, namely the United States, Canada, and Australia.
Recent Acquisitions
On October 27, 2023, IKS Health acquired Aquity Holdings, a company specializing in technology-enabled clinical documentation, medical coding, and revenue integrity solutions. This acquisition expanded IKS’s customer base by over 804 organizations as of March 31, 2024. IKS leverages cross-selling opportunities to Aquity’s clientele, enhancing its market reach and solution offerings.
Competitive Strengths
IKS Health’s position as a market leader is bolstered by the following:
- Comprehensive Platform: A one-stop solution for outpatient and inpatient care, serving diverse stakeholders such as patients, physicians, and healthcare organizations.
- Digital Transformation Expertise: Incorporating automation and outcome-driven technologies to drive sustained value.
- Strong Brand Recognition: Well-regarded among healthcare organizations and professionals.
- Scalable Business Model: Offering flexibility and cost savings to clients, with high-touch engagement through project sponsors and leadership teams.
- Cross-Selling Opportunities: Strategic collaborations and acquisitions like Aquity Holdings enable IKS to expand its market footprint.
Focus Areas
IKS Health facilitates seamless healthcare operations by focusing on:
- Reducing administrative workload to allow healthcare providers to prioritize patient care.
- Enhancing operational efficiency for outpatient and inpatient care organizations.
- Supporting healthcare enterprises in transitioning to value-based care models, optimizing revenue, and lowering operating costs.
Bidding Starts In
Inventurus Knowledge Solutions IPO Specifics:
IPO Date | December 12, 2024 to December 16, 2024 |
Listing Date | Thursday, December 19, 2024 |
Face Value | ₹1 per share |
Price Band | ₹1,265 to ₹1,329 per share |
Lot Size | 11 Shares |
Total Issue Size | 18,795,510 shares (aggregating up to ₹2,497.92 Cr) |
Offer For Sale | 18,795,510 shares (aggregating up to ₹2,497.92 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share holding pre issue | 171,573,159 |
Share holding post issue | 171,573,159 |
Inventurus Knowledge Solutions IPO Timetable (Important Dates)
IPO Open Date | Thursday, December 12, 2024 |
IPO Close Date | Monday, December 16, 2024 |
Basis of Allotment | Tuesday, December 17, 2024 |
Initiation of Refunds | Wednesday, December 18, 2024 |
Credit of Shares to Demat | Wednesday, December 18, 2024 |
Listing Date | Thursday, December 19, 2024 |
Cut-off time for UPI mandate confirmation | 5 PM on December 16, 2024 |
Inventurus Knowledge Solutions IPO Lot Size
Bidders have the opportunity to bid for a minimum of 11 shares, with the option to increase in multiples. The table below outlines the minimum and maximum investment thresholds for both retail investors and High Net Worth Individuals (HNIs), specifying the corresponding number of shares and amounts involved.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 11 | ₹14,619 |
Retail (Max) | 13 | 143 | ₹1,90,047 |
S-HNI (Min) | 14 | 154 | ₹2,04,666 |
S-HNI (Max) | 68 | 748 | ₹9,94,092 |
B-HNI (Min) | 69 | 759 | ₹10,08,711 |
Inventurus Knowledge Solutions IPO Reservation
QIB Shares Offered | Not more than 75% of the Net offer |
Retail Shares Offered | Not less than 10% of the Offer |
NII (HNI) Shares Offered | Not less than 15% of the Offer |
Inventurus Knowledge Solutions Limited IPO Financial Information
Inventurus Knowledge Solutions Limited experienced a substantial 75.25% growth in revenue and a notable 21.38% increase in profit after tax (PAT) from the financial year ending on March 31, 2023, to March 31, 2024.
Period Ended | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 30 Sept 2024 |
---|---|---|---|---|
Assets | 787.52 | 988.31 | 3027.52 | 2790.52 |
Revenue | 784.47 | 1060.16 | 1857.94 | 1294.61 |
Profit After Tax | 232.97 | 305.23 | 370.49 | 208.58 |
Net Worth | 647.07 | 828.64 | 1157.86 | 1377.11 |
Reserves and Surplus | 630.26 | 811.80 | 1140.94 | 1360.17 |
Total Borrowing | 1193.42 | 828.63 |
Key Performance Indicator – Inventurus Knowledge Solutions IPO
KPI | Values |
---|---|
Market Cap. | ₹ 22,802.07 Cr |
EPS | ₹21.59 |
P/E (x) | 61.55 |
ROE | 32% |
ROCE | 31.59% |
Debt/Equity | -0.06 |
RoNW | 32% |
P/BV | 19.07 |
Objects of the Issue:
Inventurus Knowledge Solutions Limited will not receive any proceeds from the Offer. All funds, after deducting expenses covered by the Selling Shareholders, will be directed to them. The company will not partake in these proceeds, ensuring the Selling Shareholders benefit exclusively from the net funds generated through the Offer.
Prospectus Links:
Prospectus: Official documents that provide detailed information about the IPO and the company.